Pertussis toxin permeabilization enhances the traversal of Escherichia coli K1, macrophages, and monocytes in a cerebral endothelial barrier model in vitro

International Journal of Medical Microbiology

Volumn 301, Issue 3, 2011, Pages 204-212

  Seidel, Gabriela ^a   Böcker, Kathrin ^a   Schulte, Jessica ^a   Wewer, Corinna ^a   Greune, Lilo ^a   Humberg, Verena ^a   Schmidt, M Alexander ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Blood brain barrier integrity; Coinfection; E. coli K1 and monocytes macrophages; Endothelial cells; Human brain microvascular endothelial cells (HBMEC); Pertussis toxin

Indexed keywords

PERTUSSIS TOXIN;

ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; BACTERIUM DETECTION; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN INFECTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; ESCHERICHIA COLI K1; HUMAN; HUMAN BRAIN MICROVASCULAR ENDOTHELIAL CELL; HUMAN CELL; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; NONHUMAN; PERTUSSIS; SECONDARY INFECTION;

BLOOD-BRAIN BARRIER; BORDETELLA PERTUSSIS; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ESCHERICHIA COLI; HUMANS; MACROPHAGES; MONOCYTES; PERTUSSIS TOXIN;

EID: 79951948672     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.08.018     Document Type: Article

References (57)

1. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999, 17:593-623.
2. Agerer F., Waeckerle S., Hauck C.R. Microscopic quantification of bacterial invasion by a novel antibody-independent staining method. J. Microbiol. Methods 2004, 59:23-32.
3. Amiel S.A. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. Br. J. Exp. Pathol. 1976, 57:653-662.
4. Antal J.M., Cunningham J.V., Goodrum K.J. Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three. Infect. Immun. 1992, 60:1114-1121.
5. Appleyard R.K. Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K12. Genetics 1954, 39:440-452.
6. Arimoto H., Tanuma N., Jee Y., Miyazawa T., Shima K., Matsumoto Y. Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration. J. Neuroimmunol. 2000, 104:15-21.
7. Badger J.L., Stins M.F., Kim K.S. Citrobacter freundii invades and replicates in human brain microvascular endothelial cells. Infect. Immun. 1999, 67:4208-4215.
8. Bandyopadhyay P., Xiao H., Coleman H.A., Price-Whelan A., Steinman H.M. Icm/dot-independent entry of Legionella pneumophila into amoeba and macrophage hosts. Infect. Immun. 2004, 72:4541-4551.
9. Boudeau J., Glasser A.L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 1999, 67:4499-4509.
10. Brückener K.E., el Baya A., Galla H.J., Schmidt M.A. Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J. Cell Sci. 2003, 116(Pt 9):1837-1846.
11. CDC, 2002. Pertussis - United States, 1997-2000. MMWR 51, pp. 73-76.
12. Celli J., Finlay B.B. Bacterial avoidance of phagocytosis. Trends Microbiol. 2002, 10:232-237.
13. Chang W.N., Lu C.H., Huang C.R., Chuang Y.C. Mixed infection in adult bacterial meningitis. Infection 2000, 28:8-12.
14. Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 2010, 8:26-38.
15. Ernst J.D. Bacterial inhibition of phagocytosis. Cell. Microbiol. 2000, 2:379-386.
16. Ferrari S., Donelli A., Manfredini R., Sarti M., Roncaglia R., Tagliafico E., Rossi E., Torelli G., Torelli U. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell Growth Differ. 1990, 1:543-548.
17. Geier D.A., Geier M.R. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev. 2004, 26:296-300.
18. Grant C.C., McKay E.J., Simpson A., Buckley D. Pertussis encephalopathy with high cerebrospinal fluid antibody titers to pertussis toxin and filamentous hemagglutinin. Pediatrics 1998, 102(4 Pt 1):986-990.
19. Heininger U., Kleemann W.J., Cherry J.D. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004, 114:e9-15.
20. Huang C.R., Lu C.H., Chang W.N. Adult Enterobacter meningitis: a high incidence of coinfection with other pathogens and frequent association with neurosurgical procedures. Infection 2001, 29:75-79.
21. Huang S.H., Jong A.Y. Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell. Microbiol. 2001, 3:277-287.
22. Huang S.H., Stins M.F., Kim K.S. Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect. 2000, 2:1237-1244.
23. Huang S.H., Wass C., Fu Q., Prasadarao N.V., Stins M., Kim K.S. Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10. Infect. Immun. 1995, 63:4470-4475.
24. Kim K.J., Elliott S.J., Di Cello F., Stins M.F., Kim K.S. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell. Microbiol. 2003, 5:245-252.
25. Kim K.S. Escherichia coli translocation at the blood-brain barrier. Infect. Immun. 2001, 69:5217-5222.
26. Kim K.S. Strategy of Escherichia coli for crossing the blood-brain barrier. J. Infect. Dis. 2002, 186(Suppl 2):S220-S224.
27. Kim K.S. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 2003, 4:376-385.
28. Kim K.S., Itabashi H., Gemski P., Sadoff J., Warren R.L., Cross A.S. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin. Invest. 1992, 90:897-905.
29. Kniesel U., Wolburg H. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000, 20:57-76.
30. Kügler S., Böcker K., Heusipp G., Greune L., Kim K.S., Schmidt M.A. Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell. Microbiol. 2007, 9:619-632.
31. Lehmann D., Ben-Nun A. Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J. Autoimmun. 1992, 5:675-690.
32. Lehmann M.H. Recombinant human granulocyte-macrophage colony-stimulating factor triggers interleukin-10 expression in the monocytic cell line U937. Mol. Immunol. 1998, 35:479-485.
33. Lemichez E., Lecuit M., Nassif X., Bourdoulous S. Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 2010, 8:93-104.
34. Linthicum D.S., Munoz J.J., Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 1982, 73:299-310.
35. Mandell G.L. Interaction of intraleukocytic bacteria and antibiotics. J. Clin. Invest. 1973, 52:1673-1679.
36. Menkes J.H., Kinsbourne M. Workshop on neurologic complications of pertussis and pertussis vaccination. Neuropediatrics 1990, 21:171-176.
37. Nizet V., Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 1997, 65:5074-5081.
38. Pils S., Schmitter T., Neske F., Hauck C.R. Quantification of bacterial invasion into adherent cells by flow cytometry. J. Microbiol. Methods 2006, 65:301-310.
39. Prasadarao N.V., Wass C.A., Stins M.F., Shimada H., Kim K.S. Outer membrane protein A-promoted actin condensation of brain microvascular endothelial cells is required for Escherichia coli invasion. Infect. Immun. 1999, 67:5775-5783.
40. Prasadarao N.V., Wass C.A., Weiser J.N., Stins M.F., Huang S.H., Kim K.S. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect. Immun. 1996, 64:146-153.
41. Prehm P., Schmidt G., Jann B., Jann K. The cell-wall lipopolysaccharide of Escherichia coli K-12, Structure and acceptor site for O-antigen and other substituents. Eur. J. Biochem. 1976, 70:171-177.
42. Quagliarello V., Scheld W.M. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 1992, 327:864-872.
43. Rosenberger C.M., Finlay B.B. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat. Rev. Mol. Cell Biol. 2003, 4:385-396.
44. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:2779-2783.
45. Schmidt G. Genetical studies on the lipopolysaccharide structure of Escherichia coli K12. J. Gen. Microbiol. 1973, 77:151-160.
46. Schubert-Unkmeir A., Sokolova O., Panzner U., Eigenthaler M., Frosch M. Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect. Immun. 2007, 75:899-914.
47. Sokolova O., Heppel N., Jägerhuber R., Kim K.S., Frosch M., Eigenthaler M., Schubert-Unkmeir A. Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell. Microbiol. 2004, 6:1153-1166.
48. Stins M.F., Badger J., Kim K.S. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb. Pathog. 2001, 30:19-28.
49. Stins M.F., Gilles F., Kim K.S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 1997, 76:81-90.
50. Sukumaran S.K., Prasadarao N.V. Escherichia coli K1 invasion increases human brain microvascular endothelial cell monolayer permeability by disassembling vascular-endothelial cadherins at tight junctions. J. Infect. Dis. 2003, 188:1295-1309.
51. Sukumaran S.K.S., Selvaraj S.K., Prasadarao N.V. Inhibition of apoptosis by Escherichia coli K1 is accompanied by increased expression of BclXL and blockade of mitochondroal cytochrome c release in macrophages. Infect. Immun. 2004, 72:6012-6022.
52. Tang P., Foubister V., Pucciarelli M.G., Finlay B.B. Methods to study bacterial invasion. J. Microbiol. Meth. 1993, 18:227-240.
53. Tilney L.G., Portnoy D.A. Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J. Cell Biol. 1989, 109(4 Pt 1):1597-1608.
54. Unkmeir A., Latsch K., Dietrich G., Wintermeyer E., Schinke B., Schwender S., Kim K.S., Eigenthaler M., Frosch M. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol. Microbiol. 2002, 46:933-946.
55. Valentin-Weigand P., Benkel P., Rohde M., Chhatwal G.S. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 1996, 64:2467-2473.
56. Versteegh F.G., Mooi-Kokenberg E.A., Schellekens J.F., Roord J.J. Bordetella pertussis and mixed infections. Minerva Pediatr. 2006, 58:131-137.
57. Xie Y., Kim K.J., Kim K.S. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol. Med. Microbiol. 2004, 42:271-279.